US Liquidity

Business

CN's Investor Relations Chief Stacy Alderson to Retire After Three Decades; Jamie Lockwood Named Successor

Canadian National Railway announced the retirement of veteran investor relations executive Stacy Alderson, capping a 30-year career. Vice President of Engineering Jamie Lockwood will assume the expanded role of VP, Investor Relations and Special Projects, as the railway giant navigates a strategic transition.

Jan 30, 2026

World

Panama Canal Ports Shift to Maersk After Court Annuls Chinese-Linked Firm's Concession

Panama's Supreme Court has annulled the long-term concession of Hong Kong-based CK Hutchison to operate key ports at the Panama Canal, appointing Denmark's Maersk as temporary administrator. The move follows geopolitical tensions and allegations of unpaid fees.

Jan 30, 2026

Business

Robert Half Stock Soars 26% as Recruitment Giant Signals Long-Awaited Turnaround

Shares of the staffing leader surged after its Q4 earnings hinted at a potential end to a multi-year slump, with management pointing to positive sequential growth for the first time since 2021.

Jan 30, 2026

Business

LyondellBasell Navigates 'Deepest Downturn' with Cost Cuts and Strategic Shifts Amid Trade Volatility

Facing what CEO Peter Vanacker calls the 'deepest and longest downturn' of his career, LyondellBasell reported Q1 2025 results while detailing a new $500 million cash improvement plan. The chemical giant is leaning into portfolio restructuring and its global supply network to weather trade policy uncertainty and weak demand.

Jan 30, 2026

Business

Behind the $5.6 Billion Headline: Decoding Salesforce's Landmark Army Contract

Salesforce secures a potential 10-year, $5.6 billion IDIQ contract with the U.S. Army, a strategic win for its national security unit. Yet, analysts caution the headline figure is a ceiling, not a guarantee, with real value hinging on future task orders and AI integration.

Jan 30, 2026

Business

Trump Taps Former Fed Governor Kevin Warsh for Top Central Bank Job

President Trump nominates Kevin Warsh, a former Fed governor with Wall Street ties, to succeed Jerome Powell as Federal Reserve Chair. His confirmation faces scrutiny amid questions over monetary policy direction and the central bank's political independence.

Jan 30, 2026

Business

Bitcoin's Crossroads: Navigating the Sub-$90,000 Waters as Bulls and Bears Clash

With Bitcoin consolidating below $90,000, a significant retreat from its October highs, investors are weighing whether this is a strategic entry point or a warning sign. We examine the competing narratives shaping the market's next move.

Jan 30, 2026

Business

ArcBest Navigates Prolonged Freight Downturn with Cost Cuts and Tech Investments

Despite posting a Q4 net loss, ArcBest is streamlining operations and investing in technology, positioning for a market rebound while the broader LTL sector continues its slow climb from a prolonged slump.

Jan 30, 2026

Business

Krispy Kreme Settles Data Breach Lawsuit for $1.6 Million, Affecting Over 160,000 Employees

The doughnut giant has agreed to a multimillion-dollar settlement following a 2024 cyberattack that compromised personal data of current and former staff, though it admits no fault.

Jan 30, 2026

Business

Twin Peaks Parent Company Files for Chapter 11 Bankruptcy, Casting Uncertainty Over Florida Locations

The parent company of the Twin Peaks 'breastaurant' chain has filed for Chapter 11 bankruptcy protection, raising questions about the future of its 16 Florida locations, including a Jacksonville restaurant that opened in 2023. The chain plans to remain operational during restructuring.

Jan 30, 2026

Business

Rivian's Rocky Road: Can the EV Underdog Deliver a Turnaround by 2029?

From post-IPO darling to a stock trading near historic lows, Rivian faces a critical five-year window. With new models on the horizon and a major Volkswagen partnership, analysts see a path to growth—if it can navigate fierce competition and persistent losses.

Jan 30, 2026

Business

Trump's Medicare Advantage Payment Freeze Sends Healthcare Stocks Reeling, Threatens Insurer Profits

A proposed near-zero payment increase for Medicare Advantage plans by the Trump administration has blindsided Wall Street, erasing billions in market value and raising fears of a prolonged downturn for major health insurers.

Jan 30, 2026

Business

China Reportedly Grants DeepSeek Approval to Procure Nvidia's H200 AI Chips

In a significant policy shift, Chinese authorities have reportedly cleared the AI startup DeepSeek to purchase Nvidia's advanced H200 processors, potentially easing a major hardware bottleneck for its competitive large language model.

Jan 30, 2026

Business

Markets React as Trump Taps Former Governor Kevin Warsh for Fed Chair

President Trump's nomination of Kevin Warsh, a known monetary policy hawk, to lead the Federal Reserve sent initial shockwaves through equities and bonds on Friday, raising questions about the future path of interest rates.

Jan 30, 2026

Business

Mosaic's Valuation Puzzle: Is the Fertilizer Giant Undervalued or Overpriced After Recent Rally?

Mosaic Company's shares have surged over 16% in the past month, reigniting debate among investors. A deep dive into valuation metrics reveals a stark contradiction: while a discounted cash flow model flags the stock as overvalued, its rock-bottom P/E ratio suggests significant upside potential. We break down the numbers and what they mean for long-term investors.

Jan 30, 2026

Business

Peet's Coffee to Shutter Dozens of Stores Nationwide, Citing Economic Headwinds

The iconic California-born chain Peet's Coffee is closing 27 locations, including outlets in Manhattan Beach and Redondo Beach, as it navigates post-acquisition restructuring and a challenging market for mid-size coffee retailers.

Jan 30, 2026

Business

Eli Lilly Bets $3.5 Billion on Pennsylvania as Pharma Giants Shift Production Stateside

Eli Lilly announces a massive new manufacturing facility in Pennsylvania, part of a strategic pivot by major drugmakers to onshore production amid trade tensions and soaring demand for weight-loss drugs.

Jan 30, 2026

Business

Allison Transmission's Stock Surge Sparks Valuation Debate: Momentum vs. Fundamentals

Shares of Allison Transmission Holdings (ALSN) have surged over 35% in three months, reigniting a fierce debate among analysts over whether the stock is overvalued or still trading at a deep discount to its future cash flows.

Jan 30, 2026

Business

Inventiva's Roller Coaster Ride: Biotech Stock Soars 126% in a Year Amid Volatility and Valuation Debate

French biopharma firm Inventiva (ENXTPA:IVA) has delivered a stunning 126% total return to shareholders over the past year, sharply contrasting with losses over a three-year horizon. As the stock experiences short-term pullbacks, analysts debate whether its current €5.23 price reflects future promise or present hype, with a key drug candidate hanging in the balance.

Jan 30, 2026

Business

Meta's Smart Glasses Ambitions Face Legal Hurdle as Solos Files Patent Infringement Suit

A patent lawsuit filed by Solos Technology against Meta Platforms, Oakley, and EssilorLuxottica targets core smart glasses technology, posing significant risks to Meta's wearables strategy and valuation.

Jan 30, 2026